Myocardial infarction is a leading cause of death among all cardiovascular diseases. Bone marrow mononuclear cells(BMMNCs) have become one of the candidate seed cells in treatment of myocardial infarction because of its advantages of easy separation and no immune rejection. The previous experiments in vivo have proved the improved cardiac blood circulation and systolic function in animal models after BMMNCs transplantation by producing the secretions of growth factors and other proteins to promote angiogene...
| 
推荐 
点击下列相关研究机构和相关文献作者，可以直接查到这些机构和作者被《中国知识资源总库》收录的其它文献，使您全面了解该机构和该作者的研究动态和历史。
